IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
复制标题
IGF-II 血清水平增加了良性前列腺增生和前列腺癌之间的区分,并提高了 PSA 在临床分期中的预测价值。
作者:
L. Trojan;C. Bode;C. Weiss;D. Mayer;R. Grobholz;P. Alken;M. Michel
登录
查看更多内容
影响因子:
5.8
作者:
COHEN, P;PEEHL, DM;ROSENFELD, RG
通讯作者:
ROSENFELD, RG
影响因子:
11.2
作者:
Woodson,Karen;Tangrea,JosephA;Pollak,Michael;Copeland,TerryD;Taylor,PhilipR;Virtamo,Jarmo;Albanes,Demetrius
通讯作者:
Albanes,Demetrius
DOI:
10.1210/jcem.76.4.7682560
发表时间:
1993-04
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Pinhas Cohen;D. Peehl;T. Stamey;K. Wilson;D. Clemmons;R. Rosenfeld
通讯作者:
Pinhas Cohen;D. Peehl;T. Stamey;K. Wilson;D. Clemmons;R. Rosenfeld
DOI:
10.1093/jnci/94.14.1099
发表时间:
2002
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Chan,JuneM;Stampfer,MeirJ;Ma,Jing;Gann,Peter;Gaziano,JMichael;Pollak,Michael;Giovannucci,Edward
通讯作者:
Giovannucci,Edward
DOI:
10.1210/jcem.80.12.8530586
发表时间:
1995
期刊:
The Journal of clinical endocrinology and metabolism.
影响因子:
--
作者:
Figueroa,JA;Lee,AV;Jackson,JG;Yee,D
通讯作者:
Yee,D